Phin Peng Lee

648 citations
7 papers · 558 indexed · h-index 6
Topics
Nanoparticle-Based Drug Delivery (3 papers)Barrier Structure and Function Studies (1 paper)Advancements in Transdermal Drug Delivery (1 paper)
Partner nations
United StatesSingapore

In The Last Decade

Phin Peng Lee

7 papers receiving 553 citations

Peers

Phin Peng Lee
Comparison fields: 5 of 94
  • Biomaterials 222
  • Biomedical Engineering 183
  • Organic Chemistry 148
  • Molecular Biology 133
  • Pharmaceutical Science 96
Replace Shantanu V. Lale with:
Shantanu V. Lale India
R. Krishna India
Guangyue Zu China
Jianyu Xin China
Yogita Patil‐Sen United Kingdom
Vivek S. Gaware Iceland
Vahid Jahed Iran
David I. Devore United States
Miguel Gisbert-Garzarán Spain
Arvind Dhinakar China
Phin Peng Lee relative to Shantanu V. Lale India Shantanu V. Lale's profile →
Citations per field
00.5×1.5×1.8×
Shantanu V. Lale · 1×
Citations per year

Countries citing papers authored by Phin Peng Lee

Since Specialization
Citations

This map shows the geographic impact of Phin Peng Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Phin Peng Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Phin Peng Lee more than expected).

Fields of papers citing papers by Phin Peng Lee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Phin Peng Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Phin Peng Lee. The network helps show where Phin Peng Lee may publish in the future.

Co-authorship network of co-authors of Phin Peng Lee

This figure shows the co-authorship network connecting the top 25 collaborators of Phin Peng Lee. A scholar is included among the top collaborators of Phin Peng Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Phin Peng Lee. Phin Peng Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
#WorkIndexed citations
1 3
2 25
3 49
4 50
5 70
6 276
7 85

About Phin Peng Lee

Phin Peng Lee is a scholar working on Biomaterials, Immunology and Allergy and Pharmaceutical Science, having authored 7 papers that have together received 558 indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (3 papers), Barrier Structure and Function Studies (1 paper) and Advancements in Transdermal Drug Delivery (1 paper). The work is most often cited by research in Biomaterials (222 citations), Pharmaceutical Science (96 citations) and Surfaces, Coatings and Films (50 citations). Phin Peng Lee has collaborated with scholars based in United States and Singapore. Frequent co-authors include Pui Lai Rachel Ee, James L. Hedrick, Zhan Yuin Ong, Amalina Binte Ebrahim Attia, Paula T. Hammond, Yi‐Yan Yang, Tejal A. Desai, Vuk Uskoković, Kathleen E. Fischer and So Young Yoo. Their work appears in journals such as ACS Nano, Biomaterials and Acta Biomaterialia.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026